Medical Malpractice Attorneys Report FDA Recall of Cardiac Science AEDs

The US Food and Drug Administration has issued a class 1 recall for a number of Cardiac Science’s Automated External Defibrillators (AEDs). A class 1 recall, as described on the FDA’s website, is issued for

“dangerous or defective products that predictably could cause serious health problems or death. Examples of products that could fall into this category are a food found to contain botulinal toxin, food with undeclared allergens, a label mix-up on a life saving drug, or a defective artificial heart valve.”

The FDA’s recall comes after Cardiac Science issued their own voluntary recall of the same products. Medical malpractice attorneys urge patients who may be affected by these recalls to speak with their doctors immediately and contact an attorney. Below is the FDA’s actual announcement.

new jersey philadelphia medical malpractice lawyers, medical malpractice attorneys

Medical Malpractice Attorneys in New Jersey and Philadelphia

If you or a loved one may be affected by this or any other FDA recall, contact the personal injury and medical malpractice attorneys of Messa & Associates by calling 1-877-MessaLaw, or by submitting an online inquiry for a free case evaluation.

Personal Injury Lawyers: Medical Device Maker Agrees to Pay Penalty for Selling Unapproved Devices

new jersey personal injury lawyers, attorneys, philadelphia, medical malpracticePersonal injury lawyers at Messa & Associates, P.C. have recently come across news stating that Globus Medical Inc., a spinal implant manufacturer, will pay the U.S. Food and Drug Administration $1 million in penalties for selling its NuBone Osteoinductive Bone Graft product after the FDA rejected the device in 2009.

The FDA learned that Globus was distributing the NuBone Osteoinductive, despite being told that the medical device was not substantially equivalent (NSE) to legally-marketed products, during a September 2010 inspection. The company also ignored multiple warnings given by the FDA to stop selling the device, according to a commissioner for regulatory affairs.

The settlement requires Globus Medical to pay a $550,000 penalty fee and the company’s CEO, David Paul, to pay an additional $450,000 fine.

Personal Injury Lawyers: FDA Approval Process Required NuBone Osteoinductive Devices to Be Substantially Equivalent

The FDA currently uses two procedures to approve medical devices. Clinical trials are necessary to get approval for more critical devices. However, Globus Medical’s NuBone Osteoinductive is considered a medical device that poses a lower level of risk to patients. Therefore, Globus Medical was only required to show that the NuBone Osteoinductive was substantially equivalent to similar medical devices that are already on the market.

Personal Injury Lawyers in Philadelphia and New Jersey

The Philadelphia personal injury lawyers at Messa & Associates are experienced at handling cases involving pharmaceutical and medical device injuries. Our extremely skilled team of personal injury lawyers and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have been injured by a defective medical device, a negligent medical provider, or have endured any other type of personal injury, contact the personal injury lawyers of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.

For immediate assistance, click the CHAT LIVE button to your right.

Personal Injury Lawyers Warn of Fatal Complications with Bath Refinisher

new jersey personal injury lawyers, phildelphia, attorneysPersonal injury lawyers recently came across an announcement made by the U.S. Centers for Disease Control and Prevention regarding a common paint stripping chemical that is often used to refinish bathtubs. The substance, called methylene chloride, is commonly used as a paint remover or degreaser in industrial and home improvement products.

The CDC’s announcement served as a warning against using any products containing the substance which Michigan State University research discovered was the cause for 13 deaths between 2000 and 2011. The 13 victims were workers who had used methylene chloride products to refinish bathtubs.

In its weekly report, the CDC commented on the 13 deaths, saying:

“Each death occurred in a residential bathroom with inadequate ventilation. Protective equipment, including a respirator, either was not used or was inadequate to protect against methylene chloride vapor.’’

The report went on to say that the chemical “has been recognized as potentially fatal to furniture strippers and factory workers but has not been reported previously as a cause of death among bathtub refinishers.”

The Centers for Disease Control and Prevention explained that using the chemical in confined spaces that lack sufficient ventilation is quite dangerous. In the same report, it urged labor safety organizations and public health agencies to “communicate the extreme hazards” of using the product under the wrong conditions. The author of the report, Michigan State’s Kenneth Rosenman, suggested to leave the product out of bathrooms entirely, citing that the vapors are heavier than air and linger after applications. Rosenman went on to explain:

“To use products containing methylene chloride safely, work areas must be well-ventilated, and when levels of methylene chloride exceed recommended exposure limits, workers must use protective equipment. In a small bathroom, it is unlikely these products can be used safely.’’

Personal Injury Lawyers in New Jersey and Philadelphia

Without proper warning, 13 workers used a product to complete a job and ended up losing their lives. Thirteen people died to refinish bathtubs. Dangerous products and chemicals, such as methylene chloride, should always come with proper warnings and clear safety instructions. It should not take research studies executed after the fact to determine that a product is dangerous.

If you or a loved one have been injured by a dangerous or defective product, contact the New Jersey personal injury attorneys of Messa & Associates, P.C. for a free legal consultation. Call 1-800-MessaLaw or submit a free online inquiry.

Medical Malpractice Lawyers Could Bring Class-Action Suit Against Pfizer for Defective Birth Control Pills

new jersey medical malpractice lawyers, philadelphia medical malpractice attorneys, nj medical malpractice, philadelphia personal injuryA mass recall of defective birth control pills could result in unwanted pregnancies for the women taking the recalled Pfizer birth control pills. Pfizer recalled 14 lots of Lo/Ovral-28 tablets and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets after discovering some of the blister packs may contain either too many or too few active pills and that the pills may be out of sequence. About one million packets of birth control pills are being recalled because of the error that could cause unintended pregnancies. Medical malpractice lawyers intend to bring a class-action suit against Pfizer for this severe negligence.

Medical Malpractice Lawyers Could Recover Millions in Damages for Women As A Result of Unwanted Pregnancies

Experts say wrongful pregnancy cases in the past have been looked at as being similar to medical malpractice cases, such as suing for an unwanted pregnancy after a botched vasectomy. One expert also points out that there has even been a case where a woman successfully sued a pharmacist for medical malpractice when she became pregnant as a result of an error made in filling the woman’s birth control prescriptions.

A class-action lawsuit on behalf of multiple women affected by the recall of the defective Pfizer birth control pills could potentially cost Pfizer millions in court. Thirty-two states recognize Pfizer has said that the defective birth control pills do not pose a health risk to the women that take them, but that they may not prevent pregnancy.

Medical Malpractice Lawyers in Philadelphia and New Jersey

The Philadelphia medical malpractice lawyers at Messa & Associates are experienced at handling cases resulting from medical and pharmaceutical errors. Our extremely skilled team of medical malpractice lawyers and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you or a loved one have suffered personal injuries as a result of a medical or pharmaceutical error or any other type of negligent care received by a medical provider, contact the medical malpractice lawyers of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.

Birth Defects Attorneys: Study Links Topiramate to Oral Birth Defects

While pregnant, women need to be especially careful about what foods and medications that they put into their bodies. Early in the first trimester, while many women are not even aware that they are pregnant, the baby is at a heightened risk for birth defects due to medications being ingested by their mother. Our birth defects attorneys have been writing for months about the drug Topamax and its connection to cleft lip and palate birth defects.

Mothers Taking Active Ingredient in Topamax Three Times More Likely to have Children with Birth Defects

new jersey philadelphia birth defects attorneys topamax topiramate studiesA recent study called Comparative Safety of Topiramate During Pregnancy, performed by researchers from Harvard University, MassGeneral Hospital for Children, and Loyola University in Chicago, has come to the conclusion that topiramate increases chances of birth defects. According to the study, women who take the active ingredient in the medication Topamax during their first trimester of pregnancy increase the risk of their children being born with major oral birth defects. The study analyzed statistics of 6,456 pregnant women and “compared the frequency of adverse pregnancy outcomes for those who had used topiramate during their first trimester to a control group.” The results were that the children whose mothers took topiramate were almost three times more likely to be born with a birth defect, 3.8 %, than the mothers who did not, 1.3 %.

Birth Defects Lawyers in New Jersey and Philadelphia

If you are a pregnant and currently taking Topamax or any drug containing topiramate, speak with your doctor as soon as possible about other, safer options. If you are a parent who has recently given birth to a child who suffers from a birth defect that you believe can be attributed to a prescription drug, contact the Mininno Law Office to speak with birth defects lawyers and discuss your legal rights. You may also call for a free case evaluation and consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.

Birth Defects Attorneys Reveal List of Anti-Convulsants Causing Birth Defects

It is no secret that pregnant women have difficulty with medications, as many medicines and drugs can have extremely adverse effects on a fetus. Birth defects attorneys remind pregnant women to always check with their OB/GYN before taking any medications.

Because medicines can have such devastating effects on a pregnancy, a pregnant woman’s medicinal treatment is usually quite limited. For pregnant women suffering from epilepsy, that treatment is about to become even more limited.

Topamax, the FDA, and AdverseEvents, Inc.

birth defects attorneys in nj and pa Months ago, the Mininno Law Office blog posted about the anti-epileptic drug Topamax, which was shown to cause oral malformations, such as cleft lip or cleft palate, in newborns whose mothers took the drug during pregnancy. The FDA recently changed the drug’s classification from Class C, which is a drug that displayed adverse fetal effects during animal testing, to Class D, which is a classification for drugs that display “positive evidence of human fetal risk.” Now, a litany of other anti-epileptic drugs have been added to a list of drugs that are dangerous to fetuses.

Unfortunately, thanks to the competitive nature of Big Pharma, attorneys, consumer protection and/or patient advocacy groups, and private companies are the people releasing information about the dangers these drugs pose when taken during gestation; dangers as told by the FDA’s Adverse Events Reporting System.

AdverseEvents Inc. is a private company that analyzes the FDA’s adverse drug event database for use in the healthcare industry. AdverseEvents Inc. discovered that the following drugs had as many as 25 reports of birth defect related complications.

  1. Carbatrol/Tegretol – head and facial deformities, spina bifida, and heart defects
  2. Depacon/Kene/Kote – neural tube defects, craniofacial defects, cardiovascular malformations
  3. Dilantin – oral/heart malformations, growth/mental retardation, Fetal Hydantoin Syndrome
  4. Keppra – skeletal problems, slowed growth (before and after birth)
  5. Klonopin – Oral malformations (cleft lip/palate), limb defects, infant withdrawal
  6. Lamictal – cleft lip, cleft palate
  7. Neurontin – spina bifida
  8. Trileptal – craniofacial defects, miscarriage
  9. Zonegran – spina bifida, cerebral palsy, cleft lip/palate

None of the above drugs have had classifications changes from the FDA, but for a few, it is only a matter of time.

Birth Defects Attorneys in New Jersey and Philadelphia

If you are a pregnant and currently taking any of the aforementioned anti-epileptic drugs, speak with your doctor as soon as possible about other, safer options. If you are a parent who has recently given birth to a child who suffers from a birth defect that you believe can be attributed to one of the above prescription drugs, contact the Mininno Law Office to speak with birth defects attorneys and discuss your legal rights. You may also call for a free case evaluation and consultation at 856-833-0600 in New Jersey, or 215-567-2380 in Philadelphia.

Medical Malpractice Attorneys: Compensation For Botched Circumcision

Judge Rex Heeseman of the Los Angeles Superior Court has approved a settlement for $4.6 million. The approval concludes a lawsuit which was filed following a botched circumcision procedure. The young baby, only a week old at the time of his circumcision, had 85% of the top of his penis removed. Medical malpractice attorneys say that this is a great victory for the young child, now eight years old, and his mother, Melanie Hall, who decided to file the case. The defendants in the case were Miltex Inc. and its parent company, Integra Life Sciences Holding Corp. who manufactured the clamp that was used during the procedure.

Defective Product Leads to Medical Malpractice

new jersey philadelphia medical malpractice attorneys circumcision Maternity Center vermontDr. Anthony Pickett, who was dismissed as a defendant, performed the circumcision on January 3, 2003 at Maternity Center of Vermont. The doctor was using a Militex Mogen clamp which removed eighty five percent of the top of the boy’s penis. The young boy’s medical malpractice attorneys said, “because of the defective design of the circumcision clamp, there was no protection for the head of the penis and Dr. Pickett was unable to visualize the head when excising the foreskin.” The lawyers working the case earned the plaintiffs $3.07 million in the settlement after fees and costs were deducted. Although the boy needs to regularly visit a physician and may need additional surgery in the future, they believe this is a great victory for the boy and a way to secure his financial future. Although medical malpractice statutes appeared as though they may limit the available recovery in this case, the lawyers were able to earn a just result for the young boy.

Medical Malpractice Attorneys in New Jersey and Philadelphia

If you or a family member has recently been the victim of medical negligence, it is possible that you would like to speak with our professionals. Please contact the Mininno Law Office for a free case evaluation, or call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.

Defective Products Attorneys Secure $40 Million Verdict for Victim’s Family

new jersey philadelphia defective products attorneys kia motors tiffany stablerDefective products attorneys work to serve two groups of people: their immediate clients who have been injured and are in need of compensation, and the public at large, who are put into harm’s way with a defective product.

Recently, in Alabama, a verdict was found against KIA Motors for the death of 16 year old Tiffany Stabler, who was tragically killed after being ejected from her KIA as a result of a collision. Tiffany’s father purchased the car as a gift, and took it to the dealership to make sure everything was in working order. If the recall had been issued in time, Tiffany would still be alive today.

In 2002, KIA recalled nearly 190,000 vehicles from 1995-1998 for defective seat belts, which made a latch noise, but never closed. However, this recall was a month too late for Tiffany, who was killed before the recall was issued. The family’s defective products attorneys were able to secure a sizable judgment for the family, which they most certainly deserve.

How Defective Products Attorneys Help the Public

The Stabler family’s defective products attorneys assisted the Stabler family in receiving compensation, for sure. But they have also helped the public at large, by winning a judgment that will surely make KIA Motors re-think it’s business practices in order to make cars safer for consumers. When a product is defective, defective product attorneys are an important part of the system to insure that market forces mandate a change in the manufacturing of that product. Changing dangerous products is beneficial to everyone as a whole.

Defective Products Attorneys of New Jersey and Philadelphia

If you or your family members have been injured by a defective product, it is important to act quickly to protect your legal rights. Our experienced professionals are available to assist you in getting the compensation you and your family deserve. Contact the Mininno Law Office for a free case evaluation or call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.

Defective Products: Plaintiffs Win Class Action Drywall Lawsuit

A tentative settlement was reached earlier this month in a defective products lawsuit involving Florida homeowners and the supplier of Chinese drywall. The settlement amount is a reported $54.5 million dollars, which is to be used to repair Florida homes. It is estimated that between two and three thousand homes have been infiltrated by this defective drywall. The defective products lawsuit was brought after it was discovered that the drywall contained dangerous toxins that were corroding pipes and electrical wiring and giving off foul odors which led to headaches and breathing problems.

Over a Million Sheets of Drywall Sold in Florida

new jersey philadelphia defective products attorneys banner supply Class Action Drywall LawsuitA Miami company, Banner Supply, sold 1.4 million sheets of the defective drywall to various builders throughout the state of Florida. Homeowners will now be compensated due to the corrosive material that was used in their homes. This problem, with Chinese drywall, began to grow in the time after Hurricanes Katrina and Rita hit the southern coast. Chinese drywall was imported into the States in large numbers as the call to rebuild homes grew louder.

Following the discovery of the defective nature of the drywall, countless lawsuits were filed against various distributors, manufacturers, and installers, including Banner Supply. Banner Supply believes that they were lied to about the overall quality of the drywall when they purchased the defective products from Knauf Group, a German distributor. Although Banner and their insurers were forced to pay out for this large settlement, it is foreseeable that they will seek damages from the actual manufacturers and distributors that previously handled these defective products. It is not quite clear who is truly at fault for the defective drywall, it could be the Chinese manufacturer, the German distributor, or the American supplier. In any event, it is a great win for Florida plaintiffs who suffered from the defective drywall. This settlement should allow many homeowners to replace the Chinese drywall in an effort to make their homes a safer place.

Defective Products Lawyers in New Jersey and Philadelphia

If you have recently been injured due to a defective product, it is possible that you have some questions. Please contact the Mininno Law Office for a free case evaluation, or call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.

Topamax Associated with Cleft Palate and Oral Malformations

Topamax has been a popular drug in recent years to treat epilepsy and migraine headaches. Recent studies have shown that the drug may be a factor in the development of birth defects and injuries like cleft lip or cleft palate when taken during the first trimester of pregnancy.

FDA Acknowledges Birth Injury Dangers Associated with Topamax

new jersey philadelphia birth injury attorneys tomapax associated birth defectsOn March 4, 2011, the FDA issued a safety alert regarding the risk of oral malformations, and included the risk in a warning label that is now to be placed on each bottle of Topamax. The FDA also changed the pregnancy class that Topamax belongs to to Class D. Class D pregnancy drugs are categorized as those that can potentially present significant and unnecessary harm to a human fetus.

The findings come from studies performed by the North American Anti-epileptic Drug Pregnancy Registry. They concluded that birth defects, such as cleft lip or cleft palate, were at a higher occurrence when fetuses were exposed to topiramate (Topamax) during gestation.

The FDA has advised that Topamax not be prescribed for pregnant women unless the situation is life-threatening and safer drugs have been deemed ineffective.

Birth Injury Lawyers in New Jersey and Philadelphia

If your child was born with a birth defect that you believe can be attributed to your use of Topamax during pregnancy, contact the Mininno Law Office for a free case evaluation. You may also call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.
Let the birth injury lawyers at the Mininno Law Office earn you the compensation you need and deserve.